|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Jane Z. Reed, PhD, MA, discusses some of the challenges facing pharma researchers and executives; the benefit NLP can bring; and some specific customer-use cases (covering patent landscaping, gene disease associations, access to safety silos, and more).
|
|
|
Karima Yadi, MSc, and Lionel Maritan, MSc, believe identifying enhanced needle solutions and offering integrated system solutions to serve the chronic disease market is a great step toward addressing improved patient outcomes and adherence.
|
|
|
Ed Trappler and John A. Merhige, MEM, believe it is no longer sufficient to put a product in a vial, and the future of healthcare products places increasing demands on the industry to provide innovations for delivering combination products.
|
|
|
Pascal Dugand, Thomas Megard, and Séverine Duband explain how controlling the needle insertion speed can reduce the shock on the prefilled syringe, which can reduce the risk of glass breakage, and will allow a smooth transition to syringe emptying.
|
|
|
|
|
|
|
|
|

Credence MedSystems is setting a new standard in drug delivery, helping you differentiate your products through innovative delivery systems while preserving your trusted processes. Simple, safe, and intuitive usability creates a better, safer experience for patients and healthcare professionals. Innovative designs provide safety activation clicks, end-of-dose feedback cues, and automatic needle retraction — without changes to familiar injection procedures. Our unique product innovations coexist with your existing processes, avoiding disruption to your filling lines and simplifying your secondary packaging operations. Use the primary container and components of your choice. Maintain your preferred sourcing strategy and manufacturing processes. Click here for more.
|
|
|
|
|
|
 |
|
Please join Quotient Sciences’ Vice President of Pharmaceutical Sciences, Dr. Andy Lewis, on May 20 at 10 AM London/11 AM Brussels or 6 PM London/1 PM New York for a live webinar on modified-release formulation…
|
|
 |
|
Mitsubishi Chemical Corporation recently announced its subsidiary Mitsubishi Chemical America, Inc. has entered into a definitive agreement to acquire all of the issued and….
|
|
 |
|
Trio Pharmaceuticals, Inc. and Ajinomoto Bio-Pharma Services recently announced a development collaboration agreement to evaluate AJICAP, a proprietary site-specific conjugation technology offered by…
|
|
 |
|
Stevanato Group, a leading producer of glass primary packaging and provider of integrated capabilities for combination products and Cambridge Design Partnership (CDP), a UK- and US-based leading technology and product design partner, recently….
|
|
 |
|
Catalent, Inc. recently announced a collaboration with the Janssen Pharmaceutical Companies of Johnson & Johnson, whereby Catalent’s Biologics business unit will accelerate availability of manufacturing capacity and…
|
|
 |
|
Updated daily, coverage includes top line epidemiology, the current active pipeline, vaccine development, diagnostic tests, recent news and clinical trials.
|
|
 |
|
Pivotal recently announced it has been contracted to provide specialized clinical research services in a clinical trial to study the efficacy and safety of hyperimmune plasma, obtained from…
|
|
|
|
|
Upcoming eNewsletter Features:
May 13 – Particle Design Technology
May 20 – Nasal Drug Delivery
|
|
|
|
|
|
|
|